MiMedx Reports, As A Result Of Co.'s Interim Progress Report Submitted Oct. 31, 2018, Nasdaq Has Reconsidered Co.'s Request For Continued Listing And Trading Will Be Suspended As Of Thurs., Nov. 8, 2018